Abstract
In order to further clarify the pathogenesis and clinical significance of MRI white matter abnormalities in treated hyperphenylalaninaemia (HPA), ten patients (seven type I HPA, two type II and one type III) underwent T2 relaxometry (n=8) and/or1H spectroscopy (n=7) in addition to conventional MR spin-echo imaging at 1.5 T. Two patients with severe MRI abnormalities had repeat examinations during and after a 6-to 8-month period of strict diet control. The clinical evaluation included a detailed neurological examination. In nine out of ten patients visual evoked potentials (VEP) were obtained parallel to the MR examination. MR imaging demonstrated typical symmetrical areas of prolonged T2 relaxation time predominantly in the posterior periventricular white matter in all but one of type I and II patients. There was no consistent relationship between MRI findings and time of diagnosis/initiation of therapy, IQ or visual evoked potential changes. MRI abnormalities tended to be more severe in patients with poor dietary control and high current plasma phenylalanine levels, whereas a normal MRI was found only in patients with plasma phenylalanine levels continuously below 0.36 mmol/l. There was marked regression of MRI abnormalities already after 3 months of strict diet control. T2 relaxometry showed a bi-exponential behaviour of T2 in the affected white matter, with a slow component of about 200–450 ms, indicating an increase in free (extracellular) water.1H spectroscopy revealed no signs of severe neuronal damage. We conclude, that the observed white matter changes in treated HPA probably represent reversible structural myelin changes rather than permanent demyelination.
Similar content being viewed by others
Abbreviations
- Cho:
-
choline
- Cr:
-
total creatinine
- CSF:
-
cerebrospinal fluid
- CT:
-
computed tomography
- HPA:
-
hyperphenylalaninaemia
- MR1:
-
magnetic resonance imaging
- NAA:
-
N-acetylaspartate
- Phe:
-
phenylalanine
- PKU:
-
phenylketonuria
- TE:
-
echo time
- TR:
-
repetition time
- VEP:
-
visual evoked potentials
References
Armsbach J-P, Gounut D, Rumbach L, Chambron J (1991) In vivo determination of multiexponential T2 relaxation in the brain of patients with multiple sclerosis. Magn Reson Imaging 9: 107–113
Avison MJ, Herschkowitz N, Novotny EJ, Petroff OAC, Rothman DL, Colombo JP, Bachmann C, Shulman RG, Prichard JW (1990) Proton NMR observation of phenylalanine and an aromatic metabolite in the rabbit brain in vivo. Pediatr Res 27: 566–570
Barkovich AJ, Kjos BO, Jackson DE, Norman D (1988) Normal maturation of the neonatal and infant brain: MR imaging at 1.5 T. Radiology 166: 173–180
Barkovich AJ, Lyon G, Evrard P (1992) Formation, maturation, and disorders of white matter. AJNR 13:447–461
Battistini S, Stefano N de, Parlanti S, Frederico A (1991) Unexpected white matter changes in an early treated PKU case and improvement after dietary treatment. Funct Neurol 6: 177–180
Bauman ML, Kemper TL (1982) Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria. Acta Neuropathol (Berl) 58: 55–63
Behbehani AW, Krtsch H, Schulte FJ (1981) Cranial computerized tomography in phenylketonuria. Neuropediatrics 12: 295–302
Bick U, Fahrendorf G, Ludolph A. Ullrich K (1989) MR imaging of the brain in patients with hyperphenylalaninemia (abstract). Abstracts of the 27th SSIEM Annual Symposium, Munich, p 23
Bick U, Fahrendorf G, Ludolph AC, Vassallo P, Weglage J, Ullrich K (1991) Disturbed myelination in patients with treated hyperphenylalaninemia: evaluation with magnetic resonance imaging. Eur J Pediatr 150: 185–189
Bird CR, Hedberg M, Drayer BP, Keller PJ, Flom RA, Hodak JA (1989) MR assessment of myelination in infants and children: usefulness of marker sites. AJNR 10: 731–740
Blaskovics ME, Koch R, Nelson M, Philappart M (1990) MRI's and treatment in hyperphenylalaninemic patients (abstract). Abstracts of the 28th SSIEM Annual Symposium, Birmingham, p 89
Bottomley PA, Hardy CJ, Argersinger RE, Allen-Moore G (1987) A review of1H nuclear magnetic resonance relaxation in pathology: are T1 and T2 diagnostic? Med Phys 14: 1–37
Brant-Zawadzki M (1988) MR imaging of the brain. Radiology 166: 1–10
Brismar J, Aqeel A, Gascon G, Ozand P (1990) Malignant hyperphenylalaninemia: CT and MR of the brain. AJNR 11: 135–138
Brody BA, Kinney HC, Kloman AS, Gilles FH (1987) Sequence of central nervous system myelination in human infancy. I. An autopsy study of myelination. J Neuropathol Exp Neurol 46: 283–301
Bruhn H, Frahm J, Gyngell ML, Merboldt, Hänicke W, Sauter R (1989) Cerebral mebabolism in man after acute stroke: new observations using localized proton NMR spectroscopy. Magn Res Med 9: 126–131
Burri R, Steffen C, Stieger S, Brodbeck U, Colombo JP, Herschkowitz N (1990) Reduced myelinogenesis and recovery in hyperphenylalaninemic rats. Correlation between brain phenylalanine levels, characteristic brain enzymes for myelination and brain development. Mol Chem Neuropathol 13: 57–69
Deber CM, Reynolds SJ (1991) Central nervous system myelin: structure, function and pathology. Clin Biochem 24: 113–134
Dwivedy AK, Shah SN (1982) Effects of phenylalanine and its deaminated metabolites on Na+, K+-ATPase activity in synaptosomes from rat brain. Neurochem Res 7: 717–725
Fischer HW, Haverbeke Y van, Schmitz-Feuerhake I, Muller RN (1989) The uncommon longitudinal relaxation dispersion of human brain white matter. Magn Reson Med 9: 441–446
Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R (1989) Localized high-resolution proton NMR spectroscopy using stimulated echoes: ihitial applications to human brain in vivo. Magn Reson Med 9: 79–83
Giovanni M, Valsasina R, Villani R, Ducati A, Riva E, Landi A, Longhi R (1988) Pattern reversal visual evoked potentials in phenylketonuria. J Inherited Metab Dis 11: 416–421
Grodd W, Krägeloh-Mann I, Klose U, Sauter R (1991) Metabolic and destructive brain disorders in children: findings with localized MR spectroscopy. Radiology 181: 173–181
Hecke P van, Marchal G, Johannik K, Demaerel P, Wilms G, Carton H, Baert AL (1991) Human brain proton localized NMR spectroscopy in multiple sclerosis. Magn Reson Med 18: 199–206
Herschkowitz N (1988) Brain development in the fetus, neonate and infant. Biol Neonate 54: 1–19
Hommes FA, Matsuo K (1987) On a possible mechanism of abnormal brain development in experimental hyperphenylalaninemia. Neurochem Int 11: 1–10
Huether G, Kaus R, Neuhoff V (1982) Brain development in experimental hyperphenylalaninaemia: myelination. Neuropediatrics 13: 177–182
Johannik K, Hecke P van, Francois B, Smet M, Jaeken J, Baert A (1992) Localized proton NMR spectroscopy in patients with phenylketonuria (abstract). Abstracts of the 30th SSIEM Annual Symposium, Leuven, P 12
Kamman RL, Go KG, Brouwer W, Berendsen HJC (1988) Nuclear magnetic resonance relaxation in experimental brain edema: effects of water concentration, protein concentration, and temperature. Magn Reson Med 6: 265–274
Knaap MS van der, Grond J van der, Rijen PC van, Faber JAJ, Valk J, Willemse K (1990) Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology 176: 509–515
Koch R, Azen CG, Hurst N, Gross Friedman E, Fishler K (1987) The effects of diet discontinuation in children with phenylketonuria. Eur J Pediatr 146 [Suppll]: A12-A16
Koenig SH, Brown III RD, Spiller M, Lundbom N (1990) Relaxometry of brain: why white matter appears bright on MRI. Magn Reson Med 14: 482–495
Korinthenberg R, Ullrich K, Füllenkemper F (1988) Evoked potentials and electroencephalography in adolescents with phenylketonuria. Neuropediatrics 19: 175–178
Leuzzi V, Fabbrizi F, Antonozzi I, Gualdi G, Biasi C di, Trasimeni G (1992) Neuroradiological (NMR) examination in PKU patients: clinical and biochemical correlation (abstract). Abstracts of the 30th SSIEM Annual Symposium, Leuven, P11
Lou HC, Toft PB, Andresen J, Mikkelsen I, Olsen B, Güttler F, Wieslander S, Henriksen O (1992) An occipito-temporal syndrome in adolescents with optimally controlled hyperphenylalaninaemia. J Inherited Metab Dis 15: 687–695
Ludolph AC, Ullrich K, Nedjat S, Masur H, Bick U (1992) Neurological outcome in 22 treated adolescents with hyperphenylalaninemia. A clinical and electrophysiological study. Acta Neurol Scand 85: 243–248
Matsuo K, Hommes F (1987) Regional distribution of the phenylalanine-sensitive ATP-sulphurylase in brain. J Inherited Metab Dis 10: 62–65
Matthews PM, Francis G, Antel J, Arnold DL (1991) Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology 41: 1251–1256
Mirowitz S, Sartor K, Gado M, Torack R (1989) Focal signalintensity variations in the posterior internal capsule: normal MR findings and distinction from pathologic findings. Radiology 172: 535–539
Nowell MA, Grossman RI, Hackney DB, Zimmerman RA, Goldberg HI, Bilaniuk LT (1988) MR imaging of white matter disease in children. AJR 151: 359–365
Pearson KD, Gean-Marton AD, Levy HL, Davis KR (1990) Phenylketonuria: MR imaging of the brain with clinical correlation. Radiology 177: 437–440
Pietz J, Schmidt E, Kutscha A, Meyding-Lamade U (1992) Sustained attention deficits and white matter changes (MRI) in phenylketonuria (PKU) (abstract). J Clin Exp Neuropsychol 14: 388
Press GA, Barshop BA, Haas RH, Nyhan WL, Glass RF, Hesselink JR (1989) Abnormalities of the brain in nonketotic hyperglycinemia: MR manifestations. AJNR 10: 315–321
Reynolds R, Burri R, Mahal S, Herschkowitz N (1992) Disturbed myelinogenesis and recovery in hyperphenylalaninemia in rats: an immunohistochemical study. Exp Neurol 115: 347–367
Schad LR, Brix G, Zuma I, Härle W, Lorenz WJ, Semmler W (1989) Multiexponential proton spin-spin relaxation in MR imaging of human brain tumors. J Comput Ass Tomogr 13: 577–587
Schmidt H, Mahle M, Michel U, Pietz J (1987) Continuation vs discontinuation of low-phenylalanine diet in PKU adolescents. Eur J Pediatr 146 [Suppl 1]: A17-A19
Scriver CR, Kaufman S, Woo SLC (1989) The hyperphenylalaninemias. In: Scriver CR, Baudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease I, 6th edn. McGraw Hill, New York, pp 495–546
Shaw DWW, Weinberger E, Maravilla KR (1990) Cranial MR in phenylketonuria. J Comput Assist Tomogr 14: 458–460
Shaw DWW, Maravilla KR, Weinberger E, Garretson J, Trahms CM, Scott CR (1991) MR imaging of phenylketonuria. AJNR 12: 403–406
Smith L, Beasley MG, Ades AE (1990) Intelligence and quality of dietary treatment in phenylketonuria. Arch Dis Child 65: 472–478
Taylor EH, Hommes FA (1983) Effect of experimental hyperphenylalaninemia on myelin metabolism at later stages of brain development. Int J Neurosci 20: 217–228
Thompson AJ, Smith I, Brenton D, Youl BD, Rylance G, Davidson DC, Kendall B, Lees AJ (1990) Neurological deterioration in young adults with phenylketonuria. Lancet 336: 602–605
Thompson AJ, Smith I, Kendall BE, Youl BD, Brenton D (1991) Maghetic resonance imaging changes in early treated patients with phenylketonuria. Lancet 337: 1224 (Letter)
Toma P, Oddone M, Lucigrai G, Cerone R, Romano C, Pelizza A (1991) Phenylketonuria (PKU): brai magnetic resonance (MR) findings (abstract). Neuropediatrics 22: 174
Valk J, Knaap MS van der (1989) Magnetic resonance of myelin, myelination and myelin disorders. Springer, Berlin Heidelberg New York
Villasana D, Butler IJ, Williams JC, Roongta SM (1989) Neurological deterioration in adult phenylketonuria. J Inherited Metad Dis 12: 451–457
Waisbren SE, Schnell RR, Levy HL (1980) Diet termination in children with phenylketonuria: a review of psychological assessments used to determine outcome. J Inherited Metab Dis 3: 149–153
Walter JH, Tyfield LA, Holton JB, Johnson C (1992) Magnetic resonance imaging, biochemical control and genetic analysis in patients with phenylketonuria (abstract). Abstracts of the 30th SSIEM Annual Symposium, Leuven, P 10
Wässer S, Dietrich J, Theile H, Bergmann L (1985) Korrelation klinischer, elektroenzephalographischer und computertomographischer Befunde bei Phenylketonurie. Z Klin Med 40: 1207–1210
Weglage J, Fünders B, Wilken B, Schubert D, Schmidt E, Burgard P, Ullrich K (1992) Psychological and social findings in adolescents with phenylketonuria. Eur J Pediatrics 151:522–525
Zamaroczy D, Schluesener HJ, Jolesz FA, Sobel RA, Colucci VM, Weiner HL, Sandor T (1991) Differentiation of experimental white matter lesions using multiparametric magnetic resonance measurements. Invest Radiol 26: 317–324
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bick, U., Ullrich, K., Stöber, U. et al. White matter abnormalities in patients with treated hyperphenylalaninaemia: Magnetic resonance relaxometry and proton spectroscopy findings. Eur J Pediatr 152, 1012–1020 (1993). https://doi.org/10.1007/BF01957228
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01957228